Log in to post a reply
Dec 30, 2017 06:08PM
Dec 30, 2017 06:15PM
This is a poor and flawed statistical study of community dwelling people looking if reported calcium and D intake prevented development of OP, NOT a study of people with known osteoporosis, much less osteoporosis with known decline in bone density from osteopenia to osteoporosis and on AI, and absolutely does not recommend docs move to stopping calcium or D in people with OP.
The Endocrine Society still recommends full-blown osteoporosis be treated not just to target a 25-hydroxy vitamin D over 30 ( even better is 40-60) but in addition to adequate calcium from diet or supplements at 1.2-1.5 gm elemental/day in divided doses, (citrate rather than carbonate if on acid blockers) which alone is rarely adequate, also recommends use of other additional rx, such as bisphosphonate antiresorptives ( alendronate or zometa or similar) or denosumab ( trade name prolia), if no known contraindications. Prolia has additional anti-BC action in bone as a double benefit but insurance does not always cover.
Ruling out other contributing causes of seconday OP is also important (hyperparathyroidism, hyperthyrodisim, etc.), and there are other options too.
Ask your primary care for referral to a board-certified endocrinologist, they are generally the best trained for OP management, not internists, not rheumatologists, not orthopedists, and sadly also not most oncologists.
Weight-bearing exercise, no smoking, and limited alcohol, plus aggressive fall prevention, are also important lifestyle issues.
After a decade of autoimmune problems, Dx 10/2017 at age 63, IDC, Left, 9mm, Oncotype 13, Stage IA, Grade 1, 0/5 nodes, ER+/PR+, HER2-, 11/22/2017 Lumpectomy, Arimidex. Declined radiation.